ImaginAb’s CEO, Ian Wilson, will present and lead a discussion hosted by the Oxford Global, entitled, “Translational Immuno-Oncology & Biomarkers” on April 8th
Ian will present, “The Value of In Vivo Imaging in the Clinical Development of IO Drugs”. John Rossi, Head of Translational Medicine, SVP Research, Cero Therapeutics will join as a panel member. We look forward to a robust discussion.